Wall Street Zen downgrades CVS Health stock to Buy
Published on 10/06/2026 at 14:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CVS Health Corp. (ISIN US1266501006) was trading at EUR 76.91 at Lang & Schwarz on October 6, 2026 at 2:03 p.m. CEST. According to MarketBeat on October 3, 2026, Wall Street Zen downgraded CVS Health from strong buy to Buy.
Analyst ratings remain broadly positive
MarketBeat counted 23 analysts covering CVS Health, with 22 Buy ratings and one Hold rating. The average twelve-month price target was USD 107.24, while the reported 52-week range was USD 69.51 to USD 110.68.
Investing.com reported on October 1, 2026, that Cantor Fitzgerald reiterated an Overweight rating and a USD 110.00 price target. The target is USD 33.09 above the Lang & Schwarz price, but the currencies differ, so the comparison is directional rather than a calculated premium.
Second-quarter results support the outlook
CVS Health reported USD 106.10 billion in revenue for the second quarter of 2026, up 7.30 percent from the prior-year quarter, according to MarketBeat. Earnings per share reached USD 2.58 versus a USD 1.87 consensus estimate, a USD 0.71 difference.
The company set fiscal 2026 earnings-per-share guidance at USD 7.90 to USD 8.10. That range gives the market a quantified earnings frame ahead of the next report.
November 4 sets the next test
CVS Health said on October 5, 2026, that it will discuss third-quarter 2026 results with analysts on November 4, 2026, at 8:00 a.m. ET, according to CVS Health. The date puts medical-cost trends, pharmacy performance and the guidance range back at the center of the next company update.
The euro quote trails its prior close
CVS Health Corp. was trading at EUR 76.91 at Lang & Schwarz on October 6, 2026 at 2:03 p.m. CEST, down 0.86 percent versus the prior close of EUR 77.58 on October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of CVS Health stock.
CVS Health stock facts
- Company: CVS Health Corp.
- ISIN: US1266501006
- Ticker: CVS
- Primary exchange: NYSE
- Price Lang & Schwarz as of October 6, 2026, 2:03 p.m. CEST: EUR 76.91
- Change versus prior close: minus 0.86 percent
- Prior close Lang & Schwarz October 5, 2026: EUR 77.58
- Market capitalization: USD 111.0 billion as of October 6, 2026
- 52-week range: USD 69.51-110.68
- Sector / Industry: Healthcare / Healthcare Plans
- Index membership: S&P 500
- Next earnings date: November 4, 2026
